NCT03860519
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- NorthShore University HealthSystem Evanston, Illinois, United States
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,751 public trials
635 recruiting studies
Hypersensitivity, Immediate trial results
NCT02627989
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- Tsu, Mie-ken, Japan
NCT01346371
- Conditions
- Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
- Locations
-
- Minnesota Eye Consultants, P.A. Minneapolis, Minnesota, United States
Completed
Determining Baseline Respiratory Duty Cycles in Subjects With and Without Airway Hyperresponsiveness
NCT04001465
- Conditions
- Airway Hyper Responsiveness, Hypersensitivity, Hypersensitivity, Immediate, +3 more
- Locations
-
- Asthma Research Lab - University of Saskatchewan Saskatoon, Saskatchewan, Canada
NCT00440245
- Conditions
- Asthma, Bronchial Diseases, COPD, +12 more
- Locations
-
- University of Saskatchewan Saskatoon, Saskatchewan, Canada
NCT04324918
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Gangnam Severance Hospital. Seoul, South Korea
Completed
Topical NanoDox® for Atopic Dermatitis
NCT02910011
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- UF HealthStreet Gainesville, Florida, United States
- UF Health Springhill Gainesville, Florida, United States
NCT04167280
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- University of Saskatchewan Saskatoon, Saskatchewan, Canada
NCT04314999
- Conditions
- Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +13 more
- Locations
-
- University Hospital Basel Basel, Switzerland
Completed
Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
NCT01979016
- Conditions
- Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Chicago, Illinois, United States
- New York, United States
- Dallas, Texas, United States
- Montreal, Quebec, Canada